<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E114F0B4-0B6C-4E3A-9066-2CC60A83A311"><gtr:id>E114F0B4-0B6C-4E3A-9066-2CC60A83A311</gtr:id><gtr:name>Meteorological Office UK</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:department>Peninsula Medical School</gtr:department><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E114F0B4-0B6C-4E3A-9066-2CC60A83A311"><gtr:id>E114F0B4-0B6C-4E3A-9066-2CC60A83A311</gtr:id><gtr:name>Meteorological Office UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/117997BB-6BA2-4A56-9C7E-58A4331DF5B6"><gtr:id>117997BB-6BA2-4A56-9C7E-58A4331DF5B6</gtr:id><gtr:firstName>William</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Henley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902158"><gtr:id>154C1D11-ADFA-4438-B3AF-B70D4791BDAD</gtr:id><gtr:title>Fair comparisons of interventions: extending the Prior Event Rate Ratio method</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0902158</gtr:grantReference><gtr:abstractText>To assess the effects of a treatment we typically compare health outcomes in a group of patients who received the treatment ? the treated group ? with outcomes in a group who did not ? the untreated group. There are two main approaches to conducting such comparisons: randomized trials and observational studies. 

Trials are experiments which involve randomly deciding which patients should be in the treated and untreated groups. Making the selection random ensures the groups are comparable prior to the start of treatment, with no reason to suppose one group will be older or younger, sicker or healthier, and so on. Following treatment, comparison of the two groups gives a fair assessment of the effects of treatment. 

Observational studies differ from a randomized trial in that here the researchers do not play an active part in determining who gets the treatment. Information for such studies could come from routinely collected health data, such as the records of General Practitioners. The treated and untreated groups may differ, for example, in terms of severity of illness, or age, or gender. Such factors need to be taken into account when making treatment comparisons or incorrect conclusions may be reached. 

Observational studies are often easier to conduct than trials but lack of information about factors influencing who received the treatment can make it hard to tell whether differences between the groups relate to the treatment or to something else. For this reason, randomized trials are usually considered superior ? but they are time-consuming, expensive, and cannot be carried out in some situations for ethical reasons.

The aim of this project is to extend a promising statistical method for using information from observational studies in a way that allows us to discount pre-existing differences between the treated and untreated groups, and focus our attention on the effects of treatment. We can do this by assessing differences between the groups before anyone receives the treatment. Making use of this information allows us to identify consequences relating specifically to the treatment.

Extending this method (the ?Prior Event Rate Ratio?) to a wider range of situations will offer opportunities to assess the effects of treatments when trials are not possible and allow us to identify situations in which trials should be carried out. One important application of this research would be to the development and monitoring of new treatments for chronic health conditions such as arthritis, asthma and diabetes.</gtr:abstractText><gtr:technicalSummary>In many situations where it is not ethical or practical to perform randomized controlled trials, observational studies provide a rich source of information for assessing effectiveness of treatment interventions. Unfortunately, the modest effects of modern medical treatments can be obscured by the confounding effects of other, often unmeasured, factors. There is a growing literature on methods for addressing residual confounding but recent research highlights the limitations of existing techniques. 

A recently proposed and very promising solution to this problem is the Prior Event Rate Ratio (PERR) method. This method is applicable to studies where a new intervention is introduced for the first time and is based on the assumption that differences in outcomes between treated and control groups before intervention reflect the effect of all confounders, independent of the intervention effect. Simple adjustments are then possible to correct estimates of intervention effects for the aggregate effects of confounders. Previous work has shown the potential of the PERR method to remove or reduce residual confounding when analyzing effectiveness of new drug treatments using routine clinical databases. 

This project will broaden the scope of this method by investigating its suitability for analysis of intervention effects more generally, including hazardous exposures that would not be possible to test experimentally, in both cohort and routine clinical studies. An extensive simulation study will be performed to explore sensitivity of the method to different assumptions about issues encountered in practice including multiple unmeasured confounders, attrition bias, measurement error and differential mortality. An important contribution of our work will be the extension of the PERR approach to address the analysis of ordinal and interval outcomes, both central to research on chronic health conditions in mid and later life. 

The PERR method can be seen as creating a form of ?natural experiment? and has similarities to the ?controlled before-and-after? study design used in psychology and economics. One of our primary objectives will be to investigate differences in model specification and develop an integrated framework for quasi-experimental approaches in epidemiological applications. Following a detailed literature review we will make comparisons with selected alternative approaches to controlling residual confounding, such as instrumental variables, propensity scoring and Bayesian bias analysis. 

The proposed work will develop new tools to make more effective use of observational databases, and has the potential to make a substantial contribution to evidence-based medicine and the assessment of risks from environmental hazards not amenable to experimental investigation.</gtr:technicalSummary><gtr:fund><gtr:end>2014-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-12-06</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>510879</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Meteorological Office UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Modelling observational data for health protection</gtr:description><gtr:id>1B76831E-9342-4258-AAD4-68602123683F</gtr:id><gtr:impact>Submission of an application to establish an NIHR Health Protection Research Unit in Modelling Methodology. The research team was shortlisted to submit a full application and selected for interview but was not awarded funding.</gtr:impact><gtr:outcomeId>e8skRPXUznH-2</gtr:outcomeId><gtr:partnerContribution>Southampton research team has provided expertise in modern biostatistical methods.
Met Office research team has provided expertise in climate/weather modelling and forecasting.</gtr:partnerContribution><gtr:piContribution>Exeter research team has led the development and submission of an application to establish an NIHR Health Protection Research Unit in Modelling Methodology. Key focus of the application was on statistical methods for making effective use of routinely collected data.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR CLAHRC South West Peninsula</gtr:department><gtr:description>Clinical applications of PERR</gtr:description><gtr:id>6E10A203-CAF8-43D6-B681-32ECE37F9AAA</gtr:id><gtr:impact>First paper being drafted on effectiveness of influenza vaccination.</gtr:impact><gtr:outcomeId>LMLk6G9ZLPL-1</gtr:outcomeId><gtr:partnerContribution>Funding of a PhD studentship to develop a series of case studies.
Input from clinicians and the public to ensure that our research focuses on applied questions that reflect real clinical concerns.</gtr:partnerContribution><gtr:piContribution>Application of quasi-experimental methods to evaluating the effectiveness of treatments and services in clinical practice using data from the Clinical Practice Research Datalink (CPRD).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Southampton Statistical Sciences Research Institute</gtr:department><gtr:description>Modelling observational data for health protection</gtr:description><gtr:id>399B31A4-FDBB-4773-B0A6-F3175A527769</gtr:id><gtr:impact>Submission of an application to establish an NIHR Health Protection Research Unit in Modelling Methodology. The research team was shortlisted to submit a full application and selected for interview but was not awarded funding.</gtr:impact><gtr:outcomeId>e8skRPXUznH-1</gtr:outcomeId><gtr:partnerContribution>Southampton research team has provided expertise in modern biostatistical methods.
Met Office research team has provided expertise in climate/weather modelling and forecasting.</gtr:partnerContribution><gtr:piContribution>Exeter research team has led the development and submission of an application to establish an NIHR Health Protection Research Unit in Modelling Methodology. Key focus of the application was on statistical methods for making effective use of routinely collected data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>236000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research for Patient Benefit</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C91FF473-6B07-4F05-9526-7EB738A44BC8</gtr:id><gtr:outcomeId>56d8cd3acdefd0.46012792</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>080B39A5-8B8A-472C-BB26-D2F0E7C90610</gtr:id><gtr:title>Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological review.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4a305eec26923f3ea63131546c93176"><gtr:id>a4a305eec26923f3ea63131546c93176</gtr:id><gtr:otherNames>Streeter AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>5a35e147923059.69472854</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2112F8B1-D620-4B7F-811A-A2519D227733</gtr:id><gtr:title>Bias and sensitivity analysis when estimating treatment effects from the cox model with omitted covariates.</gtr:title><gtr:parentPublicationTitle>Biometrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900b69d2c109c59f0d085fe70e715679"><gtr:id>900b69d2c109c59f0d085fe70e715679</gtr:id><gtr:otherNames>Lin NX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-341X</gtr:issn><gtr:outcomeId>RkuV6UtZHGS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB5D3EAF-52AB-47EB-972C-9A972B007CC1</gtr:id><gtr:title>Prior event rate ratio adjustment for hidden confounding in observational studies of treatment effectiveness: a pairwise Cox likelihood approach.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900b69d2c109c59f0d085fe70e715679"><gtr:id>900b69d2c109c59f0d085fe70e715679</gtr:id><gtr:otherNames>Lin NX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>585d322ea26126.74251275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75DDFD3D-7BEF-4A9B-8CD6-1D0C7EA049AF</gtr:id><gtr:title>Improved curve fits to summary survival data: application to economic evaluation of health technologies.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aafe56aab7b5e71c559448a9731aab93"><gtr:id>aafe56aab7b5e71c559448a9731aab93</gtr:id><gtr:otherNames>Hoyle MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>pm_13452_22_21985358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9735D161-12B6-4EC6-9FE4-406511AAA989</gtr:id><gtr:title>Assessing long-term postoperative cognitive decline using conventional and quasi-experimental approaches: A Monte Carlo simulation study</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; Dementia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba120ad0efef8b4c8420f4874b56f752"><gtr:id>ba120ad0efef8b4c8420f4874b56f752</gtr:id><gtr:otherNames>Llewellyn D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>cu6YmaoANbv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07575820-B3F0-4A64-B552-D5968AD53F02</gtr:id><gtr:title>Sensitivity analysis when estimating treatment effects from survival data with omitted covariates</gtr:title><gtr:parentPublicationTitle>Population Health - Methods and Challenges Conference</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d7d617ba9c637e8b14483447ac4e040"><gtr:id>5d7d617ba9c637e8b14483447ac4e040</gtr:id><gtr:otherNames>Lin, Nan Xuan</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>gsRe53igbTV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60457A8F-3970-4748-A07D-5049AC695568</gtr:id><gtr:title>A modified Prior Event Rate Ratio (PERR) approach to assessing treatment effects using electronic clinical databases</gtr:title><gtr:parentPublicationTitle>Population Health - Methods and Challenges Conference</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff1261deb0aabe903449be43a4d0367c"><gtr:id>ff1261deb0aabe903449be43a4d0367c</gtr:id><gtr:otherNames>Henley, William</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>kg9HLNsX4WM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E936DE48-3FA2-4721-8872-8AF0433A3E64</gtr:id><gtr:title>Adjusting for unmeasured confounding in non-randomised longitudinal studies: a methodological review</gtr:title><gtr:parentPublicationTitle> Accepted</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/281bb6e7f8f660c9249bbb2eeb799c79"><gtr:id>281bb6e7f8f660c9249bbb2eeb799c79</gtr:id><gtr:otherNames>Streeter A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c08f28512546.88502973</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902158</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>